Translations:Diabetes medication/12/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
14,847 edits
Importing a new version from external source
 
(No difference)

Latest revision as of 12:09, 4 February 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Diabetes medication)
As a systematic review of studies comparing insulin detemir, insulin glargine, insulin degludec and NPH insulin did not show any clear benefits or serious [[Side effect|adverse effects]] for any particular form of insulin for nocturnal [[hypoglycemia]], severe hypoglycemia, [[glycated hemoglobin]] A1c, non-fatal [[myocardial infarction]]/[[stroke]], [[Quality of life (healthcare)|health-related quality of life]] or [[all-cause mortality]]. The same review did not find any differences in effects of using these insulin analogues between adults and children.

As a systematic review of studies comparing insulin detemir, insulin glargine, insulin degludec and NPH insulin did not show any clear benefits or serious adverse effects for any particular form of insulin for nocturnal hypoglycemia, severe hypoglycemia, glycated hemoglobin A1c, non-fatal myocardial infarction/stroke, health-related quality of life or all-cause mortality. The same review did not find any differences in effects of using these insulin analogues between adults and children.

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Diabetes_medication/12/en&oldid=110556"